Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Anplag on Betaloc Disposition
NCT02097511Phase 1Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Dec 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sarpogrelate in peripheral artery disease (PAD) (3 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Plasma concentration of Metoprolol and metabolites up to 12 hours. Started Dec 2013; status: completed.
02
Drugs
sarpogrelate
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT02097511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097511.